Cannabinoids show potential as new treatments for inflammatory bowel disease (IBD),
exerting several favourable effects in the gut, including anti-inflammatory and …

The components of the endogenous cannabinoid system are widely expressed in the
gastrointestinal tract contributing to local homeostasis. In general, cannabinoids exert …

The endocannabinoid system is involved in the regulation of gastrointestinal (GI) motility and
inflammation. Using the peripherally restricted, cannabinoid CB1/CB2 receptor agonist …

The endocannabinoid system is involved in the regulation of gastrointestinal (GI) motility and
inflammation. Using the peripherally restricted cannabinoid (CB) 1/CB2 receptor agonist …

In this mini‐review, we focus on the potential of the endocannabinoid system as a target for
novel therapies to treat gastrointestinal (GI) inflammation. We discuss the organization of the …

We have studied the effect of cannabinoid agonists (CP 55,940 and cannabinol) on
intestinal motility in a model of intestinal inflammation (induced by oral croton oil in mice) …

Background Cannabinoid agents and cannabis are frequently used for relief of diverse
gastrointestinal symptoms. Purpose The objective of this article is to increase the awareness …

Δ9‐Tetrahydrocannabinol (the active ingredient of marijuana), as well as endogenous and
synthetic cannabinoids, exert many biological functions by activating two types of …

Many beneficial effects of herbal and synthetic cannabinoids on gut motility and
inflammation have been demonstrated, suggesting a vast potential for these compounds in …

Cannabinoids have been shown to exert anti-inflammatory and anti-nociceptive functions in
many models of human disease. We recently provided evidence that the synthetic …